Eupraxia Pharmaceuticals (EPRX) Change in Receivables (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) recorded Change in Receivables of -$26,168 in the quarter ended Jun 30, 2026, compared with $112,771 a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Change in Receivables (2023 - 2026) Analysis & Trends
On a TTM basis, Eupraxia Pharmaceuticals' Change in Receivables came in at -$537,749 as of Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$431,449.
- Across earlier years, Change in Receivables came in at -$101,389 in the year ended Dec 31, 2024, -$103,710 in the year ended Dec 31, 2023 and $230,481 in the year ended Dec 31, 2022.
- Quarterly Change in Receivables has ranged from -$528,267 in the quarter ended Dec 31, 2025 to $112,771 in the quarter ended Jun 30, 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at $23,964 (quarter ended Mar 31, 2026), -$528,267 (quarter ended Dec 31, 2025) and -$7,278 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.35 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.37 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.09 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 333.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 308.46 Mn | -133.60 Mn | - | -26,168.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26,168.00 |
| Mar 31, 2026 | 23,964.00 |
| Dec 31, 2025 | 334,631.00 |
| Sep 30, 2025 | -7,278.00 |
| Jun 30, 2025 | 112,771.00 |
| Mar 31, 2025 | -8,675.00 |
| Dec 31, 2024 | 20,085.00 |
| Sep 30, 2024 | 50,432.00 |
| Jun 30, 2024 | 13,671.00 |
| Mar 31, 2024 | 17,201.00 |
| Dec 31, 2023 | 83,213.00 |
| Sep 30, 2023 | -17,845.00 |
| Jun 30, 2023 | 36,654.00 |
| Mar 31, 2023 | 1,688.00 |
API Access
Eupraxia Pharmaceuticals Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();